TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).

Esther Natalie Oliva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.